*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Cetilistat (CAS <strong>282526-98-1</strong>) is an oral lipase inhibitor developed for obesity management. Its molecular formula is C<sub>30</sub>H<sub>47</sub>NO<sub>4</sub>. The compound is synthesized via asymmetric hydrogenation and esterification, targeting pancreatic enzymes to reduce fat absorption.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical R&D:</strong> Used as a reference standard in anti-obesity drug formulation studies.</li>
<li><strong>Clinical Trials:</strong> Investigated as a standalone therapy or combination agent for weight loss interventions.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly limited to clinical settings due to potential gastrointestinal side effects. Store in a cool, dry place under inert atmosphere to prevent hydrolysis. Handle with PPE to avoid skin contact.</p>